Straus F H, Kaplan E L, Nishiyama R H, Bigos S T
Surgery. 1983 Dec;94(6):901-5.
Lipoadenoma is the accepted diagnosis of a single enlarged parathyroid gland that contains large quantities of mature fat cells and focal myxoid stroma, all widely separating small parenchymal cell nests in patients with hyperparathyroidism. Here we are reporting, for the first time, on five cases of hyperparathyroidism in which all four parathyroid glands are enlarged and each gland is noted to have an admixture of fat and parenchymal cells. We will introduce the descriptive diagnosis of lipohyperplasia to name this condition and keep it in perspective with other forms of parathyroid disease. All five patients were women between the ages of 36 and 62 years who underwent neck exploration, at which time four enlarged light-tan parathyroid glands were observed. Three and one half gland resections were performed, and all patients returned to a normocalcemic state except one who had borderline serum hypercalcemia after operation. Most of the resected parathyroid glands weighed in the range of 100 to 200 mg. The largest measured gland weighed 820 mg. Parathyroid histology showed an admixture of mature fat cells with parathyroid parenchymal cells often in a 1:1 ratio. One patient who had renal failure exhibited a lower ratio of fat cells. Two patients had chronic lymphocytic thyroiditis that was severe enough to require synthetic thyroid hormone therapy. Two patients had a history of urinary tract infections. Three patients had hypertensive cardiovascular disease, and several patients had arteriosclerotic cardiovascular disease. One patient had diabetes mellitus, one had a history of pituitary adenoma, and one had polydipsia. All of these patients were first seen with parathyroid glands measuring an average of five times normal size, yet they showed the usual 50% fat/50% parenchyma pattern of normal mature parathyroid glands. This means that the enlarged glands contain a 500% increase in parathyroid tissue, justifying the diagnostic term "lipohyperplasia." This easily represents enough parathyroid tissue to generate excessive parathyroid hormone production. At this time, there is no explanation of the pathogenesis of lipohyperplasia or how it varies from other previously described forms of parathyroid hyperplasia.
脂肪腺瘤是指单个增大的甲状旁腺,其中含有大量成熟脂肪细胞和局灶性黏液样基质,这些成分将甲状旁腺功能亢进患者的小实质细胞巢广泛分隔开来。在此,我们首次报告5例甲状旁腺功能亢进病例,其中所有4个甲状旁腺均增大,且每个腺体均可见脂肪与实质细胞混合存在。我们将引入脂肪增生的描述性诊断来命名这种情况,并将其与其他形式的甲状旁腺疾病相区分。所有5例患者均为36至62岁的女性,均接受了颈部探查,术中观察到4个增大的浅棕色甲状旁腺。进行了3.5个腺体切除,除1例术后血清钙处于临界高值外,所有患者均恢复到血钙正常状态。大多数切除的甲状旁腺重量在100至200毫克之间。最大的测量腺体重820毫克。甲状旁腺组织学显示成熟脂肪细胞与甲状旁腺实质细胞混合存在,比例通常为1:1。1例肾衰竭患者脂肪细胞比例较低。2例患者患有慢性淋巴细胞性甲状腺炎,严重程度足以需要接受合成甲状腺激素治疗。2例患者有尿路感染病史。3例患者患有高血压性心血管疾病,数例患者有动脉粥样硬化性心血管疾病。1例患者患有糖尿病,1例有垂体腺瘤病史,1例有多饮症状。所有这些患者首次就诊时甲状旁腺平均大小为正常大小的5倍,但它们呈现出正常成熟甲状旁腺通常的50%脂肪/50%实质的模式。这意味着增大的腺体中甲状旁腺组织增加了500%,这证明了“脂肪增生”这一诊断术语的合理性。这很容易代表足以产生过量甲状旁腺激素的甲状旁腺组织量。目前,对于脂肪增生的发病机制或其与先前描述的其他甲状旁腺增生形式的差异尚无解释。